Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

bipartisan house task force on artificial intelligence

About that bipartisan $32B ‘roadmap’ for AI policy: What’s in it for healthcare?

This week Washington took a major step toward nailing down a solid game plan on federal AI spending for everything outside of defense.

MDMA Ecstasy

FDA set to evaluate use of ‘ecstasy’ for treating PTSD

The party drug could soon be prescribed, in conjunction with psychological interventions, as a treatment for mental health disorders.

FDA announces another new recall involving Abbott’s HeartMate 3 LVADs after 70 injuries, 2 deaths

Abbott issued the new recall after receiving more than 80 reports of blood or air entering the LVAD during implant procedures. Customers can still use these devices, but they are advised to follow specific steps to limit the risk of complications. 

hospital pricing rand corporation

Rand releases bracing analysis of hospital prices; AHA repudiates approach, methodology

The Rand Corporation is reporting that, in 2022, employers and private insurers paid hospitals an average 254% more than what Medicare would have spent for the same services in the same facilities.

legal liability malpractice artificial intelligence

RateMDs sued by doctor who claims the site violates privacy laws

The lawsuit contends RateMDs has a conflict of interest and sells ads to medical professionals reviewed by users of the site.

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data. 

healthcare money economics dollar stethoscope acquire merger

Kaiser Permanente unloading $3.5B in private equity stakes

Citing sources familiar with the matter, the Wall Street Journal reported that Kaiser Permanente is working with Jefferies Financial Group to find secondary buyers.

lex Sandhu, MD, MS, assistant professor of cardiovascular medicine, Stanford University, and cardiologist at the Palo Alto VA. He spoke in the business of cardiology sessions at ACC 2024 and explained how Medicare reimbursements will be moving toward a value based payment model by 2030. #ACC #ACC24 #ACC2024 #CMS #reimbersements #Medicare

How the shift to value-based reimbursements could transform cardiology

"I think we really need our cardiologist community to understand the changes that are happening with value-based payment," one expert tells Cardiovascular Business. 

Around the web

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Trimed Popup
Trimed Popup